Woodline Partners’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.72M | Sell |
2,497,984
-157,754
| -6% | -$487K | 0.04% | 478 |
|
|
2025
Q1 | $9.27M | Buy |
2,655,738
+1,684,110
| +173% | +$5.88M | 0.06% | 373 |
|
|
2024
Q4 | $3.18M | Buy |
971,628
+303,475
| +45% | +$992K | 0.02% | 576 |
|
|
2024
Q3 | $2.57M | Sell |
668,153
-258,381
| -28% | -$995K | 0.02% | 447 |
|
|
2024
Q2 | $2.86M | Sell |
926,534
-3,144,125
| -77% | -$9.72M | 0.03% | 387 |
|
|
2024
Q1 | $10.5M | Sell |
4,070,659
-649,244
| -14% | -$1.68M | 0.1% | 257 |
|
|
2023
Q4 | $11.8M | Hold |
4,719,903
| – | – | 0.13% | 210 |
|
|
2023
Q3 | $9.58M | Buy |
4,719,903
+2,250,706
| +91% | +$4.57M | 0.11% | 229 |
|
|
2023
Q2 | $5.68M | Sell |
2,469,197
-188,408
| -7% | -$433K | 0.07% | 272 |
|
|
2023
Q1 | $8.05M | Buy |
+2,657,605
| New | +$8.05M | 0.11% | 227 |
|
|
2021
Q4 | – | Sell |
-496,172
| Closed | -$2.13M | – | 696 |
|
|
2021
Q3 | $2.13M | Buy |
+496,172
| New | +$2.13M | 0.03% | 405 |
|
|
2021
Q2 | – | Sell |
-78,339
| Closed | -$261K | – | 587 |
|
|
2021
Q1 | $261K | Buy |
+78,339
| New | +$261K | 0.01% | 405 |
|